Identification of a novel protein promoting the colonization and survival of Finegoldia magna, a bacterial commensal and opportunistic pathogen.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 2628433)

Published in Mol Microbiol on September 18, 2008

Authors

Inga-Maria Frick1, Christofer Karlsson, Matthias Mörgelin, Anders I Olin, Radmila Janjusevic, Clara Hammarström, Elisabet Holst, Maarten de Château, Lars Björck

Author Affiliations

1: Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden. Inga-Maria.Frick@med.lu.se

Articles cited by this

Basic local alignment search tool. J Mol Biol (1990) 659.07

Predicting coiled coils from protein sequences. Science (1991) 38.18

Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50

InterProScan: protein domains identifier. Nucleic Acids Res (2005) 18.82

Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35

Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev (1989) 7.80

Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56

Mammalian defensins in the antimicrobial immune response. Nat Immunol (2005) 4.84

Cell wall sorting signals in surface proteins of gram-positive bacteria. EMBO J (1993) 4.51

Antibacterial peptides: basic facts and emerging concepts. J Intern Med (2003) 4.44

Osteonectin, a bone-specific protein linking mineral to collagen. Cell (1981) 4.06

The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem (1997) 3.82

Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol (1984) 3.56

Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett (2004) 3.43

Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol (2001) 3.39

Macromolecular organization of basement membranes. Curr Opin Cell Biol (1996) 2.72

M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell (2004) 2.46

Gram-positive anaerobic cocci. Clin Microbiol Rev (1998) 2.34

Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem (1995) 2.31

SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol (2000) 2.03

Novel fold and assembly of the repetitive B region of the Staphylococcus aureus collagen-binding surface protein. Structure (2000) 1.87

Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol (2005) 1.85

Protein L. A novel bacterial cell wall protein with affinity for Ig L chains. J Immunol (1988) 1.44

Virulent aggregates of Streptococcus pyogenes are generated by homophilic protein-protein interactions. Mol Microbiol (2000) 1.43

Small colloidal gold conjugated to Fab fragments or to immunoglobulin G as high-resolution labels for electron microscopy: a technical overview. J Electron Microsc Tech (1990) 1.38

Protein H--a novel IgG binding bacterial protein. Mol Immunol (1990) 1.34

Protein PAB, a mosaic albumin-binding bacterial protein representing the first contemporary example of module shuffling. J Biol Chem (1994) 1.15

Anaerobic cocci populating the deep tissues of chronic wounds impair cellular wound healing responses in vitro. Br J Dermatol (2003) 1.13

SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc Natl Acad Sci U S A (1994) 1.10

Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen. Eur J Biochem (1991) 1.10

Encapsulated anaerobic bacteria in synergistic infections. Microbiol Rev (1986) 1.06

Complete genome sequence of Finegoldia magna, an anaerobic opportunistic pathogen. DNA Res (2008) 1.03

Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02

Protein PAB, an albumin-binding bacterial surface protein promoting growth and virulence. J Biol Chem (1996) 1.00

Structure and stability of protein H and the M1 protein from Streptococcus pyogenes. Implications for other surface proteins of gram-positive bacteria. Biochemistry (1995) 1.00

Antimicrobial peptides as effector molecules of mammalian host defense. Contrib Microbiol (2003) 0.91

SufA--a novel subtilisin-like serine proteinase of Finegoldia magna. Microbiology (2007) 0.88

Apparent culture-negative prosthetic valve endocarditis caused by Peptostreptococcus magnus. J Clin Microbiol (2000) 0.88

Potential role of anaerobic cocci in impaired human wound healing. Wound Repair Regen (2002) 0.87

Endocarditis caused by Finegoldia magna (formerly Peptostreptococcus magnus): diagnosis depends on the blood culture system used. Diagn Microbiol Infect Dis (2003) 0.85

Enzymatically active Peptostreptococcus magnus: association with site of infection. J Clin Microbiol (1992) 0.84

Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii. Microb Pathog (2001) 0.81

Characteristics of anaerobes from skin specimens. Drugs Exp Clin Res (2003) 0.81

Articles by these authors

Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol Cell Proteomics (2008) 3.29

IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J (2002) 2.77

M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell (2004) 2.46

The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragment. J Biol Chem (2002) 2.44

Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A (2013) 2.32

Antibody orientation at bacterial surfaces is related to invasive infection. J Exp Med (2012) 2.30

Heparin-binding protein: a diagnostic marker of acute bacterial meningitis. Crit Care Med (2011) 2.29

Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol (2002) 2.21

Pathogenic mechanisms in lupus nephritis: Nucleosomes bind aberrant laminin β1 with high affinity and colocalize in the electron-dense deposits. Arthritis Rheumatol (2014) 2.13

Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood (2010) 2.04

Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis (2009) 1.94

Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol (2002) 1.87

Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood (2011) 1.87

Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem (2013) 1.84

MtsABC is important for manganese and iron transport, oxidative stress resistance, and virulence of Streptococcus pyogenes. Infect Immun (2003) 1.82

Ca2+-dependent phospholipid scrambling by a reconstituted TMEM16 ion channel. Nat Commun (2013) 1.80

β₂-glycoprotein I: a novel component of innate immunity. Blood (2011) 1.75

COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem (2007) 1.74

Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J Biol Chem (2003) 1.72

Type III effector AvrPtoB requires intrinsic E3 ubiquitin ligase activity to suppress plant cell death and immunity. Proc Natl Acad Sci U S A (2006) 1.71

The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells. Biochem J (2003) 1.67

Genome-based identification and analysis of collagen-related structural motifs in bacterial and viral proteins. J Biol Chem (2003) 1.65

The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem (2005) 1.61

SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem (2003) 1.60

The protein expression of Streptococcus pyogenes is significantly influenced by human plasma. J Proteome Res (2005) 1.55

Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci U S A (2011) 1.52

Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A (2004) 1.51

Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet (2004) 1.51

[A pregnant woman with abdominal pain and fever]. Tidsskr Nor Laegeforen (2007) 1.49

Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun (2011) 1.49

Antimicrobial activities of heparin-binding peptides. Eur J Biochem (2004) 1.46

Anesthesia aggravates lung damage and precipitates hypotension in endotoxemic sheep. Shock (2010) 1.44

Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry (2004) 1.43

Activation of the human contact system on neutrophil extracellular traps. J Innate Immun (2009) 1.41

Pathogen entrapment by transglutaminase--a conserved early innate immune mechanism. PLoS Pathog (2010) 1.39

C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum (2009) 1.37

Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS One (2008) 1.37

The contact system--a novel branch of innate immunity generating antibacterial peptides. EMBO J (2006) 1.36

Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol (2006) 1.36

Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J Biol Chem (2002) 1.35

Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood (2006) 1.33

The regulator PerR is involved in oxidative stress response and iron homeostasis and is necessary for full virulence of Streptococcus pyogenes. Infect Immun (2002) 1.33

Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc Natl Acad Sci U S A (2004) 1.32

Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils. Cell Microbiol (2003) 1.29

IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc Natl Acad Sci U S A (2008) 1.27

Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol Microbiol (2002) 1.25

Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum (2010) 1.23

alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem (2004) 1.23

Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem (2002) 1.22

Suppression of sulfonylurea- and glucose-induced insulin secretion in vitro and in vivo in mice lacking the chloride transport protein ClC-3. Cell Metab (2009) 1.22

Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol (2010) 1.21

Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol (2008) 1.21

Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma. Proc Natl Acad Sci U S A (2007) 1.20

Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med (2012) 1.18

Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles. Blood (2002) 1.18

Blocking of experimental arthritis by cleavage of IgG antibodies in vivo. Arthritis Rheum (2007) 1.17

Molecular consequences of dominant Bethlem myopathy collagen VI mutations. Ann Neurol (2007) 1.15

Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins. J Biol Chem (2004) 1.15

Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity. Ann Neurol (2008) 1.14

Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin. J Biol Chem (2004) 1.14

Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Structure (2004) 1.14

A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res (2005) 1.13

Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog (2010) 1.12

Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. Biochim Biophys Acta (2007) 1.12

Interactions with fibronectin attenuate the virulence of Streptococcus pyogenes. EMBO J (2004) 1.12

Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem (2005) 1.11

Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura. Br J Haematol (2007) 1.11

IdeS: a bacterial proteolytic enzyme with therapeutic potential. PLoS One (2008) 1.10

IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes. Curr Opin Microbiol (2003) 1.09

B cell activation by outer membrane vesicles--a novel virulence mechanism. PLoS Pathog (2010) 1.09

Relative neurotoxin gene expression in clostridium botulinum type B, determined using quantitative reverse transcription-PCR. Appl Environ Microbiol (2004) 1.09

Identification of two protein-binding and functional regions of curli, a surface organelle and virulence determinant of Escherichia coli. J Biol Chem (2002) 1.09

Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration. Cardiovasc Res (2006) 1.09

Antimicrobial peptides derived from growth factors. Growth Factors (2007) 1.09

The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis (2007) 1.08

Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation. PLoS One (2012) 1.08

The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J Biol Chem (2002) 1.08

Chondroitin sulfate perlecan enhances collagen fibril formation. Implications for perlecan chondrodysplasias. J Biol Chem (2006) 1.06

Streptococcus pyogenes bacteria modulate membrane traffic in human neutrophils and selectively inhibit azurophilic granule fusion with phagosomes. Cell Microbiol (2006) 1.06

Kinked collagen VI tetramers and reduced microfibril formation as a result of Bethlem myopathy and introduced triple helical glycine mutations. J Biol Chem (2001) 1.06

The major bactericidal activity of human seminal plasma is zinc-dependent and derived from fragmentation of the semenogelins. J Immunol (2008) 1.05

Characterization of recombinant amino-terminal NC4 domain of human collagen IX: interaction with glycosaminoglycans and cartilage oligomeric matrix protein. J Biol Chem (2004) 1.05

Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma. Am J Respir Crit Care Med (2004) 1.05

Streptococcal M proteins and their role as virulence determinants. Clin Chim Acta (2010) 1.05

The dual role of the contact system in bacterial infectious disease. Thromb Haemost (2007) 1.05

Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob Agents Chemother (2011) 1.05

The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils. J Lipid Res (2011) 1.05

SpeB modulates fibronectin-dependent internalization of Streptococcus pyogenes by efficient proteolysis of cell-wall-anchored protein F1. Microbiology (2004) 1.04

Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid. Mol Immunol (2007) 1.04